Estimate of male urethritis incidences in France between 2007 and 2017 with a specific focus on Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis infections

Publié le 27 Juin 2019
Mis à jour le 02 novembre 2019

Background: in a context of increasing use of Nucleic Acid Amplification Test, diagnoses of Neisseria gonorrhoeae and Chlamydia trachomatis infections among men increased in Europe and USA since 2007. We aimed to describe trends in the incidence of male urethritis in France between 2007 and 2017. Methods: we analysed male urethritis clinical cases reported by the French GPs" Sentinelles network. Results: GPs reported 1944 cases of male urethritis during the study period. The estimated annual incidence rates in men aged 15 years and older remained stable between 226 cases per 100,000 seen in 2007 and 196 in 2017 (P value = 0.9). A third-generation cephalosporin with macrolide or tetracycline was prescribed in 17.5% of cases in 2009 (27/154) and 32.4% in 2017 (47/145) (P value = 0.0327). Conclusions: the incidence rates for adult male urethritis diagnosed in primary care have remained stable since 2007 in France in contrast with the increasing trend of Neisseria gonorrhoeae and Chlamydia trachomatis infections based on microbiological surveillance. Using stable clinical definition for male urethritis seems essential to follow correctly epidemiological dynamic.

Auteur : Rossignol Louise, Feuillepain Laurianne, Ndeikoundam Ngangro Ndeindo, Souty Cécile, Fournet Nelly, Le Strat Yann, Baroux Noémie, Hanslik Thomas, Lot Florence, Blanchon Thierry
BMC Infectious Diseases, 2019, vol. 19, p. 1-9